Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Zoller

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Antibiotics (Basel, Switzerland)|July 2, 2021
The Role of Non-Enzymatic Degradation of Meropenem-Insights from the Bottle to the BodyUwe Liebchen, Sophie Rakete, Michael Vogeser, et al.
Clinical Pharmacology and Therapeutics|June 17, 2021
A Model-Based Approach to Assess Unstable Creatinine Clearance in Critically Ill PatientsSami Ullah, Michael Zoller, Ulrich Jaehde, et al.
International Journal of Antimicrobial Agents|August 2, 2016
Variability of piperacillin concentrations in relation to tazobactam concentrations in critically ill patientsJohannes Zander, Gundula Döbbeler, Dorothea Nagel, et al.
Annals of Intensive Care|May 22, 2022
Does the cytokine adsorber CytoSorb<sup>®</sup> reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational studyChristina Scharf, Ferdinand Weinelt, Ines Schroeder, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2025
The β-lactamase inhibitor concentration-dependent minimum inhibitory concentration (MICcBLI) as methodology to assess the pharmacokinetic/pharmacodynamic relationship of piperacillin/tazobactam for dosing optimizationMalin Andersson, Franz Weber, Ferdinand Weinelt, et al.
Renal Failure|September 20, 2023
The effect of cytosorb® application on kidney recovery in critically ill patients with severe rhabdomyolysis: a propensity score matching analysisCaroline Gräfe, Uwe Liebchen, Antonia Greimel, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2023
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement TherapyLea Marie Schatz, Alexander Brinkmann, Anka Röhr, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2023
Cefepime Population Pharmacokinetics, Antibacterial Target Attainment, and Estimated Probability of Neurotoxicity in Critically Ill PatientsMuhammad Bilal, Michael Zoller, Uwe Fuhr, et al.
Critical Care (London, England)|April 5, 2016
Piperacillin concentration in relation to therapeutic range in critically ill patients--a prospective observational studyJohannes Zander, Gundula Döbbeler, Dorothea Nagel, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 21, 2018
Effect of Intraoperative Single-Shot Application of Vancomycin in Liver Transplant Recipients on Postoperative Infections With Enterococcus faecium and Enterococcus faecalisChristian Siebers, Johannes Kinzinger, Ludwig C Hinske, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Antibiotics (Basel, Switzerland)|July 2, 2021
The Role of Non-Enzymatic Degradation of Meropenem-Insights from the Bottle to the BodyUwe Liebchen, Sophie Rakete, Michael Vogeser, et al.
Clinical Pharmacology and Therapeutics|June 17, 2021
A Model-Based Approach to Assess Unstable Creatinine Clearance in Critically Ill PatientsSami Ullah, Michael Zoller, Ulrich Jaehde, et al.
International Journal of Antimicrobial Agents|August 2, 2016
Variability of piperacillin concentrations in relation to tazobactam concentrations in critically ill patientsJohannes Zander, Gundula Döbbeler, Dorothea Nagel, et al.
Annals of Intensive Care|May 22, 2022
Does the cytokine adsorber CytoSorb<sup>®</sup> reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational studyChristina Scharf, Ferdinand Weinelt, Ines Schroeder, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2025
The β-lactamase inhibitor concentration-dependent minimum inhibitory concentration (MICcBLI) as methodology to assess the pharmacokinetic/pharmacodynamic relationship of piperacillin/tazobactam for dosing optimizationMalin Andersson, Franz Weber, Ferdinand Weinelt, et al.
Renal Failure|September 20, 2023
The effect of cytosorb® application on kidney recovery in critically ill patients with severe rhabdomyolysis: a propensity score matching analysisCaroline Gräfe, Uwe Liebchen, Antonia Greimel, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2023
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement TherapyLea Marie Schatz, Alexander Brinkmann, Anka Röhr, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2023
Cefepime Population Pharmacokinetics, Antibacterial Target Attainment, and Estimated Probability of Neurotoxicity in Critically Ill PatientsMuhammad Bilal, Michael Zoller, Uwe Fuhr, et al.
Critical Care (London, England)|April 5, 2016
Piperacillin concentration in relation to therapeutic range in critically ill patients--a prospective observational studyJohannes Zander, Gundula Döbbeler, Dorothea Nagel, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 21, 2018
Effect of Intraoperative Single-Shot Application of Vancomycin in Liver Transplant Recipients on Postoperative Infections With Enterococcus faecium and Enterococcus faecalisChristian Siebers, Johannes Kinzinger, Ludwig C Hinske, et al.
Pageof 9